2005
DOI: 10.1021/jf0506481
|View full text |Cite
|
Sign up to set email alerts
|

Contents and Bioactivities of Lunasin, Bowman−Birk Inhibitor, and Isoflavones in Soybean Seed

Abstract: It has been previously demonstrated that lunasin is a novel and promising cancer preventive peptide from soybean. The Bowman-Birk protease inhibitor (BBI) and isoflavones are well-studied substances from soy. This study evaluated the levels and bioactivities of these three compounds as affected by stages of seed development and sprouting under light and dark conditions. BBI and lunasin appear at 7 and 6 weeks, respectively, after flowering and increase as the seed matures. Daidzein and genistein both decrease … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
46
0
1

Year Published

2011
2011
2022
2022

Publication Types

Select...
4
4

Relationship

1
7

Authors

Journals

citations
Cited by 51 publications
(50 citation statements)
references
References 28 publications
(30 reference statements)
3
46
0
1
Order By: Relevance
“…A notable increase of lunasin content is observed during seed maturation while the opposite occurs during sprouting. Breeding conditions (light and dark cycles) do not seem to affect the content of this peptide (Park et al, 2005). Large-scale processing of soy also influences lunasin concentration which was observed to vary from 12 to 44 mg lunasin/g of flour among different U.S. commercially available soy proteins (Gonzalez de Mejia et al, 2004).…”
Section: Structure and Bioavailabilitymentioning
confidence: 93%
See 2 more Smart Citations
“…A notable increase of lunasin content is observed during seed maturation while the opposite occurs during sprouting. Breeding conditions (light and dark cycles) do not seem to affect the content of this peptide (Park et al, 2005). Large-scale processing of soy also influences lunasin concentration which was observed to vary from 12 to 44 mg lunasin/g of flour among different U.S. commercially available soy proteins (Gonzalez de Mejia et al, 2004).…”
Section: Structure and Bioavailabilitymentioning
confidence: 93%
“…It was observed that during the process of seed maturation the contents of isoflavones decrease, whereas sprouting led to a continuing increase of isoflavone content. Interestingly, the protein extracts from the developing seeds showed clearly opposite effects on cell viability and inhibition of foci formation compared with those from sprouting seeds (Park et al, 2005). Individual differences in the absorption and metabolism of ingested isoflavones are another variable not usually addressed on breast cancer studies.…”
Section: Variables Influencing Inconsistent Outcomesmentioning
confidence: 99%
See 1 more Smart Citation
“…This variation has been found to mainly depend on the soybean genotype, suggesting the possibility of selecting and breeding varieties of soybean with higher lunasin contents [16]. The stages of seed development have also been found to affect lunasin's concentration, and a notable increase occurs during seed maturation [18]. However, sprouting leads to a continuing decrease of lunasin with soaking time.…”
Section: Lunasin: Discovery and Beyondmentioning
confidence: 99%
“…Soybean seeds devoid of BBI also showed varying concentrations of lunasin ranging from 3.3 to 16.7 ng lunasin/mg seed indicating that lunasin is still produced on soybean seed even in the absence of BBI (de Mejia and Dia, 2010b). Analysis of lunasin in Korean soybean cultivar Taekwongkong showed that lunasin appears at 6 weeks after flowering (0.01 µg/g seed) with its highest level found at maturity with concentration of 0.12 µg/g seed (Park et al, 2005). Processing also affects lunasin concentration in soybean and soybean products.…”
Section: Lunasin: Discovery and Beyondmentioning
confidence: 99%